ESC 2021 guideline updates for mitral & tricuspid regurgitation treatment | Heart Failure 2021

Drs Marco Metra, Andrew Coats and Fabien Praz explore and discuss updates to the 2020 American College of Cardiology Heart Failure and European Society of Cardiology Heart Failure 2021 guidelines for the treatment of mitral & tricuspid regurgitation, including changes to patient treatment and their clinical implications.

Agenda:
2:02: ACC 2020 Guidelines improve position of MR intervention
4:36: ESC HFA, EACVI, EHRA & EAPCI Joint Position Statement
11:53: Outcomes for MR patients undergoing TEER
20:41: ACC 2020 Guidelines improve position of TR surgical intervention (Secondary TR)
21:52: Decision algorithm for transcatheter tricuspid valve interventions
25:33: Session evaluation and key learnings

Content related to Edwards Lifesciences devices is intended for healthcare professionals. By viewing, you confirm you are a healthcare professional. The contents herein are intended for viewers in Europe excluding France.